M Gil-Delgado - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

M Gil-Delgado

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Anticancer Research|July 1, 1987

Mitoxantrone combined with vincristine, cyclophosphamide and fluorouracil for advanced breast cancer. A study of short-term response rateJ L Misset, R Metz, M Gil-Delgado, et al.

La Nouvelle Presse Medicale|January 9, 1982

[Aclacinomycin-A in acute leukaemias and leukaemic non-Hodgkin lymphomas (author's transl)]G Mathé, R de Jager, R Hulhoven, et al.

Breast Cancer Research and Treatment|November 27, 2004

Efficacy and safety of single agent capecitabine in pretreated metastatic breast cancer patients from the French compassionate use programJ Y Pierga, P Fumoleau, Y Brewer, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Anticancer Research|July 1, 1987

Mitoxantrone combined with vincristine, cyclophosphamide and fluorouracil for advanced breast cancer. A study of short-term response rateJ L Misset, R Metz, M Gil-Delgado, et al.

La Nouvelle Presse Medicale|January 9, 1982

[Aclacinomycin-A in acute leukaemias and leukaemic non-Hodgkin lymphomas (author's transl)]G Mathé, R de Jager, R Hulhoven, et al.

Breast Cancer Research and Treatment|November 27, 2004

Efficacy and safety of single agent capecitabine in pretreated metastatic breast cancer patients from the French compassionate use programJ Y Pierga, P Fumoleau, Y Brewer, et al.

Pageof 2